Skip to main content
TipRanks
Go Ultimate75% OFF

Sinovac Biotech (SVA) Q3 2019 Earnings Report

137 Followers

SVA Q3 2019 EPS Results

Actual EPS
$0.06
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
$0.24

SVA Q3 2019 Revenue Results

Actual Revenue
$64.34M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q3 2019
Date
11/15/2019
Time
Before Open
Conference Call
Friday, November 15, 2019
SVA Upcoming Earnings

Sinovac Biotech's next earnings date is estimated for May 3, 2027, based on past reporting schedules.

Q3 2019 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2019 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2019 Earnings Call Summary

No earnings call summary is available for this earnings event.

SVA Earnings History

SVA earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
May 03, 20272026 (Q4)―--0.53――
Aug 17, 20262026 (Q2)―-0.84-0.3-177.48% (-0.54)
Jun 05, 20262025 (Q4)―-0.531.37-138.50% (-1.90)
Aug 14, 20252025 (Q2)―--0.08―
May 05, 20252024 (Q4)―--1.2―
Aug 16, 20242024 (Q2)―-0.08-0.03-166.67% (-0.05)
Apr 29, 20242023 (Q4)―-1.20-3.7568.04% (+2.56)
Aug 15, 20232023 (Q2)―-0.034.22-100.71% (-4.25)
May 01, 20232022 (Q4)―-3.7533.78-111.11% (-37.54)
Dec 29, 20222022 (Q2)―4.2251.42-91.80% (-47.20)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed